Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Retained Earnings (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 15 years of Retained Earnings data on record, last reported at -$205.2 million in Q2 2025.

  • For Q2 2025, Retained Earnings fell 23.25% year-over-year to -$205.2 million; the TTM value through May 2025 reached -$205.2 million, down 23.25%, while the annual FY2025 figure was -$205.2 million, 23.25% down from the prior year.
  • Retained Earnings reached -$205.2 million in Q2 2025 per LFCR's latest filing, down from -$204.1 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $41.4 million in Q1 2021 and bottomed at -$205.2 million in Q2 2025.
  • Average Retained Earnings over 5 years is -$105.0 million, with a median of -$159.4 million recorded in 2024.
  • Peak YoY movement for Retained Earnings: surged 5081.49% in 2021, then crashed 66085.31% in 2023.
  • A 5-year view of Retained Earnings shows it stood at -$816000.0 in 2021, then tumbled by 12142.52% to -$99.9 million in 2022, then tumbled by 75.25% to -$175.1 million in 2023, then decreased by 9.36% to -$191.5 million in 2024, then fell by 7.2% to -$205.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$205.2 million in Q2 2025, -$204.1 million in Q1 2025, and -$191.5 million in Q4 2024.